8-K: Adagio Medical 2026 Annual Meeting Results

Sentiment:

Annual Meeting Results


Adagio Medical Holdings, Inc. successfully concluded its 2026 Annual Meeting with the election of two directors and the ratification of its independent auditor.

Summary

  • The 2026 Annual Meeting of Stockholders was held on June 16, 2026.
  • A total of 16,069,984 shares were represented, accounting for 72.35% of the 22,210,459 outstanding shares.
  • Orly Mishan and Sean Salmon were elected as directors to serve until the 2029 annual meeting.
  • WithumSmith+Brown, PC was ratified as the independent registered public accounting firm for the 2026 fiscal year.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing confirming standard corporate governance outcomes.

Positives

  • Strong shareholder participation with 72.35% of outstanding shares represented at the meeting.
  • Successful election of board nominees with significant 'For' votes.
  • Overwhelming support for the appointment of the independent auditor, with 16,055,195 votes in favor.

Negatives

  • None identified in this filing.

Risks

  • None identified in this filing.

Future Outlook

No specific forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that this filing represents standard corporate governance procedures for a publicly traded company, ensuring board continuity and audit oversight.

Comparison to Industry Standards

  • The 72.35% quorum achieved is consistent with typical participation levels for small-to-mid-cap emerging growth companies.
  • The ratification of an established accounting firm like WithumSmith+Brown, PC aligns with standard public company audit practices.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board ElectionElection of Orly Mishan and Sean Salmon as directors.2026-06-16Ensures board continuity and governance oversight.

Stakeholder Impact

  • Shareholders maintain continuity in board leadership.
  • The company maintains regulatory compliance through the appointment of an independent auditor.

Next Steps

  • Directors Orly Mishan and Sean Salmon will serve until the 2029 annual meeting.
  • WithumSmith+Brown, PC will proceed with the audit for the fiscal year ending December 31, 2026.

Key Dates

DateDescription
2026-04-30Definitive proxy statement filed with the SEC.
2026-06-162026 Annual Meeting of Stockholders held.

Keywords

Adagio Medical, ADGM, Annual Meeting, Proxy Results, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.